Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06743789 · ClinicalTrials.gov registry record · NA

Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions

A NA study of Ventricular Tachycardia, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06743789 is a NA study of Ventricular Tachycardia that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06743789, a NA study of Ventricular Tachycardia, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a research study that aims to understand if giving a lower dose of treatment all at once is as effective and safe as dividing it into three smaller doses for patients with a heart condition called refractory ventricular tachycardia (VT). These patients have not exhibited positive responses to conventional medications or procedures. This study aims to explore whether an alternative approach could yield more beneficial outcomes.

Conditions Studied

Interventions

  • RADIATION Radiation Therapy

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-12-18
Est. Completion 2030-12
Phase NA

What the Registry Record Tells You About NCT06743789

The ClinicalTrials.gov registry entry for NCT06743789 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (86% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.

NCT06743789 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06743789 about?

NCT06743789 is a clinical study titled "Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions". This is a research study that aims to understand if giving a lower dose of treatment all at once is as effective and safe as dividing it into three smaller doses for patients with a heart condition called refractory ventricular tachycardia (VT). These patients have not exhibited positive responses t...

What is the current status of trial NCT06743789?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-12-18. Estimated completion is 2030-12.

What conditions does trial NCT06743789 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT06743789?

The interventions under investigation include: Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT06743789?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06743789 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.